Premium
Carga viral temprana después de iniciar primera l’anea de tratamiento antirretroviral para la identificación de pacientes con alto riesgo de fracaso virológico: datos de un estudio de cohortes en condiciones de recursos limitados
Author(s) -
AlvarezUria Gerardo,
Naik Praveen Kumar,
Pakam Rhagavakalyan,
Midde Manoranjan
Publication year - 2012
Publication title -
tropical medicine and international health
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.056
H-Index - 114
eISSN - 1365-3156
pISSN - 1360-2276
DOI - 10.1111/j.1365-3156.2012.02982.x
Subject(s) - medicine , hazard ratio , viral load , confidence interval , cohort , incidence (geometry) , cumulative incidence , cohort study , antiretroviral therapy , human immunodeficiency virus (hiv) , immunology , physics , optics
Objectives To evaluate the performance of a single determination of HIV viral load (VL) 6–12 months after starting antiretroviral therapy (ART) for identifying patients who will subsequently develop virological failure. Methods We selected HIV‐infected patients with at least two VL determinations after 6 months of ART from an HIV cohort study in India. Patients were divided in two groups depending on whether the first VL was below (Group 1) or above (Group 2) 1000 copies/ml. Cut‐off for virological failure was defined according to World Health Organization recommendation (>5000 copies/ml). Results The study included 584 patients and 560.1 person‐years of follow‐up. Of all virological failures, 83% were diagnosed at the first VL determination. The cumulative incidence of virological failure after 1 and 2 years since the first VL was 0.9% [95% confidence interval (CI), 0.3–2.7] and 1.7% (95% CI, 0.6–5), respectively, for Group 1, and 58.2% (95% CI, 47–69.7) and 63.1% (95% CI, 49.8–76.4), respectively, for Group 2. Compared with Group 1, patients from Group 2 had a hazard ratio for virological failure of 78.3 (95% CI, 27.8–220.2). Conclusions A single VL determination after 6 months of ART was able to identify patients with high risk of virological failure.